Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Eloxx Pharmaceuticals(ELOX) the EPS is -0.66 (--%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EPS
-0.66--
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf